Intrahepatic Cholestasis of Pregnancy and Maternal-Fetal Results

Year 2022, Volume: 7 Issue: 1, 68 - 73, 01.03.2022

Kemine Uzel , Filiz Bilir , Bahar Sarıibrahim Astepe , Paşa Uluğ , Yusuf Kemal Arslan , Tunay Kiremitli

https://doi.org/10.26453/otjhs.1016176

Cited By: 1

Abstract

Objective: Occurring frequently after the late second trimester intrahepatic cholestasis of pregnancy (ICP) is a widespread liver disease in the period of pregnancy. The general incidence of IC depending on the geographic variations, is probably to vary from 1% to 27.6%. In the study, it was aimed to report the maternal and fetal outcomes of women with ICP at our university hospital center.
Materials and Methods: The study was performed retrospectively on 44 pregnancies complicated by ICP between June 2018 and December 2020, at our Education and Research Hospital. Demographic characteristics, liver enzymes, a gestational week at diagnosis, type and time of delivery, APGAR scores at birth, and newborn weight and information about the patients included in the study were obtained from hospital records.
Results: The number of primiparous women was 27 (61%). In 4 (9.1%) women had preeclampsia and 4 (9.1%) women had gestational diabetes mellitus (GDM). Only one of the neonates had Apgar at the birth 1/5, 0 and 0 respectively.
Conclusion: In our study one perinatal death was observed, although no adverse maternal outcomes were observed. We recommend that ICP be managed individually. Close monitoring and active management are required in the prevention of complications. 

Keywords

Intrahepatic cholestasis, pregnancy, perinatal outcomes

Gebeliğin Intrahepatik Kolestazı ve Maternal-Fetal Sonuçları

Abstract

Amaç: Sıklıkla ikinci trimesterin sonlarından itibaren ortaya çıkan intrahepatik gebelik kolestazı, gebelik döneminde görülen yaygın bir karaciğer hastalığıdır. Coğrafi varyasyonlara bağlı olarak genel insidansı %1 -%27,6 arasında değişmektedir. Bu çalışma, üniversite hastanemizde Gebeliğin İntrahepatik Kolestazı tanılı kadınların maternal ve fetal sonuçlarını bildirmeyi amaçladı.
Materyal ve Metot: Çalışma Eğitim ve Araştırma Hastanemizde, Haziran 2018-Aralık 2020 tarihleri ​​arasında Gebeliğin İntrahepatik Kolestazı (GİK) ile komplike olan 44 gebede retrospektif olarak yapıldı. Çalışmaya dahil edilen olguların (n=44) demografik özellikleri, karaciğer enzimleri, tanı aldığı gebelik haftası, doğum şekli ve zamanı, doğumda APGAR skorları, yenidoğanın kilosu ve hasta bilgileri hastane kayıtlarından alındı.
Bulgular: Primipar kadın sayısı 27 (%61) idi. 4 (%9,1) kadında preeklampsi ve 4 (%9,1) kadında gestasyonel diabetes mellitus (GDM) izlendi. Yenidoğanlardan sadece birinde doğumda 1. ve 5. dakika APGAR scorları sırasıyla 0 ve 0 idi.
Sonuç: Çalışmamızda herhangi bir olumsuz maternal sonuç gözlenmemesine rağmen, bir perinatal ölüm izlendi. GİK'nin bireysel olarak yönetilmesini öneririz. Komplikasyonların önlenmesinde yakın takip ve aktif yönetim gereklidir. 

Keywords

İntrahepatik kolestaz, gebelik, perinatal sonuçlar

References

• Reyes H, Gonzalez MC, Ribalta J, et al. Prevalence of intrahepatic cholestasis of pregnancy in Chile. Ann Intern Med. 1978;88:487-493. doi:10.7326/0003-4819-88-4-487
• Wikstrom Shemer E, Marschall HU, Ludvigsson JF, Stephansson O. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort. BJOG. 2013;120(6):717-723. doi:10.1111/1471-0528.12174
• Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol. 2009;15(17):2049-2066. doi:10.3748/wjg.15.2049
• Abedin P, Weaver JB, Egginton E. Intrahepatic cholestasis of pregnancy: prevalence and ethnic distribution. Ethn Health. 1999;4(1-2):35-7. doi:10.1080/13557859998173
• Lee RH, Goodwin TM, Greenspoon J, Incerpi M. The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol. 2006;26(9):527-532. doi:10.1038/sj.jp.7211545
• Pata O, Vardareli E, Ozcan A, et al. intrahepatic cholestasis of pregnancy: Correlation of preterm delivery with even acids. Turk J Gastroenterol. 2011;22:602-605.
• Yıldırım G, Aslan H, Gedikbaşı A, et al. In intrahepatic cholestasis pregnancy outcomes. Journal of the Turkish Society of Gynecology and Obstetrics. 2007;4:250-253.
• Heinonen S, Eloranta ML, Heiskanen J, et al. Maternal susceptibility locus for obstetric cholestasis maps to chromosome region 2p13 in Finnish patients. Scand J Gastroenterol. 2001;36(7):766-770. doi:10.1080/00365520119193
• Bacq Y. Liver diseases unique to pregnancy: A 2010 update. Clin Res. Hepatol Gastroenterol. 2011;35:182-193. doi: 10.1016/j.clinre.2010.11.011
• Glantz A, Marschall HU, Mattsson LA. Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology. 2004;40(2):467-474. doi:10.1002/hep.20336
• Saleh MM, Abdo KR. Intrahepatic cholestasis of pregnancy: review of the literature and evaluation of current evidence. J Womens Health. 2007;16(6):833-841. doi:10.1089/jwh.2007.0158
• Gorelik J, Shevchuk A, de Swiet M, Lab M, Korchev Y, Williamson C. Comparison of the arrhythmogenic effects of tauro- and glycoconjugates of cholic acid in an in vitro study of rat cardiomyocytes. BJOG Int J Obstet Gynaecol. 2004;111(8):867–870. doi:10.1111/j.1471-0528.2004.00166.x
• Lammert F, Marschall HU, Glantz A, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol. 2000;33(6):1012–1021. doi: 10.1016/s0168-8278(00)80139-7
• ACOG Committee Opinion No. 764: Medically indicated late-preterm and early-term deliveries. Obstet Gynecol. 2019;133(2):e151–e155. doi:10.1097/AOG.0000000000003083
• Marathe JA, Lim WH, Metz MP, Scheil W, Dekker AG, Hague WM. A retrospective cohort review of intrahepatic cholestasis of pregnancy in a South Australian population. Eur J Obstet Gynecol Reprod Biol. 2017;218:33-38. doi:10.1016/j.ejogrb.2017.09.012
• ACOG committee opinion no. 560: Medically indicated late-preterm and early-term deliveries. Obstet Gynecol. 2013;121(4):908-910. doi:10.1097/01.AOG.0000428648.75548.00
• Bicocca MJ, Sperling JD, Chauhan SP. Intrahepatic cholestasis of pregnancy: review of six national and regional guidelines. Obstet Gynecol Reprod Biol. 2018;231:180–187. doi:10.1016/j.ejogrb.2018.10.041
• Geenes V, Chappell LC, Seed PT, Steer PJ, Knight M, Williamson C. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: A prospective population-based case-control study. Hepatology. 2013;59(4):1482-91. doi: 10.1002/hep.26617
• Chappell LC, Bell JL, Smith A, et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet. 2019;394(10201):849–860. doi:10.1016/S0140-6736(19)31270-X
• Herrera CA, Manuck TA, Stoddard GJ et al. Perinatal outcomes associated with intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2018;31(14):1913-1920. doi:10.1080/14767058.2017.1332036
• Kohari KS, Carroll R, Capogna S et al. Outcome after implementation of a modern management strategy for intrahepatic cholestasis of pregnancy. J Matern Fetal Neonatal Med. 2017;30(11):1342-1346. doi:10.1080/14767058.2016.1212833